Substituierte Isochinolinderivate, Verfahren zu deren Herstellung sowie Arzneimittel enthaltend diese Verbindungen
申请人:F. HOFFMANN-LA ROCHE & CO.
Aktiengesellschaft
公开号:EP0126480B1
公开(公告)日:1988-01-20
US4544657A
申请人:——
公开号:US4544657A
公开(公告)日:1985-10-01
US4559403A
申请人:——
公开号:US4559403A
公开(公告)日:1985-12-17
[EN] PPARγ AGONISTS FOR TREATMENT OF KIDNEY DISEASE<br/>[FR] AGONISTES DE PPARγ POUR LE TRAITEMENT D'UNE MALADIE RÉNALE
申请人:THE RES INSTITUTE AT NATIONWIDE CHILDRENS HOSPITAL
公开号:WO2021222231A1
公开(公告)日:2021-11-04
A method of treating or preventing glomerular disease or chronic kidney disease in a subject is described. The method includes administering to the subject a therapeutically effective amount of PPARγ agonist or a pharmaceutically acceptable salt thereof.